Journal of Peking University (Health Sciences) ›› 2023, Vol. 55 ›› Issue (3): 558-562. doi: 10.19723/j.issn.1671-167X.2023.03.025
Previous Articles Next Articles
Yuan-jin ZHANG1,Jing-yue MA1,Xiang-yi LIU1,Dan-feng ZHENG2,Ying-shuang ZHANG1,Xiao-gang LI1,Dong-sheng FAN1,*()
CLC Number:
1 |
Mammen AL . Statin-associated autoimmune myopathy[J]. N Engl J Med, 2016, 374 (7): 664- 669.
doi: 10.1056/NEJMra1515161 |
2 |
Kipfer S , Frigerio S , Hench J , et al. Immune-mediated necro-tising myopathy linked to statin use[J]. Lancet, 2015, 386 (10005): e26.
doi: 10.1016/S0140-6736(15)60068-X |
3 |
Nichols L , Pfeifer K , Mammen AL , et al. An unusual case of statin-induced myopathy: Anti-HMGCoA necrotizing autoimmune myopathy[J]. J Gen Intern Med, 2015, 30 (12): 1879- 1883.
doi: 10.1007/s11606-015-3303-9 |
4 |
Christopher-Stine L , Casciola-Rosen LA , Hong G , et al. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy[J]. Arthritis Rheum, 2010, 62 (9): 2757- 2766.
doi: 10.1002/art.27572 |
5 |
Mammen AL , Chung T , Christopher-Stine L , et al. Autoanti-bodies against 3-hydroxy-3-methylglutaryl-coenzyme a reductase in patients with statin-associated autoimmune myopathy[J]. Arthritis Rheum, 2011, 63, 713- 721.
doi: 10.1002/art.30156 |
6 |
Allenbach Y , Benveniste O , Stenzel W , et al. Immune-mediated necrotizing myopathy: Clinical features and pathogenesis[J]. Nat Rev Rheumatol, 2020, 16 (12): 689- 701.
doi: 10.1038/s41584-020-00515-9 |
7 |
Mohassel P , Mammen AL . Anti-HMGCR myopathy[J]. J Neuromuscul Dis, 2018, 5 (1): 11- 20.
doi: 10.3233/JND-170282 |
8 |
Turner RM , Pirmohamed M . Statin-related myotoxicity: A comprehensive review of pharmacokinetic, pharmacogenomic and muscle components[J]. J Clin Med, 2019, 9 (1): 22.
doi: 10.3390/jcm9010022 |
9 |
Kurashige T . Anti-HMGCR myopathy: Clinical and histopathological features, and prognosis[J]. Curr Opin Rheumatol, 2021, 33 (6): 554- 562.
doi: 10.1097/BOR.0000000000000832 |
10 |
Ghannam M , Manousakis G . Case report: immune mediated necrotizing myopathy with IgG antibodies to 3-Hydroxy-3-methylglutaryl-coenzyme a reductase (HMGCR) may present with acute systolic heart failure[J]. Front Neurol, 2020, 11, 571716.
doi: 10.3389/fneur.2020.571716 |
11 |
Karunaratne K , Amiras D , Pickering MC , et al. Autoimmune necrotising myopathy and HMGCR antibodies[J]. Pract Neurol, 2018, 18 (2): 151- 155.
doi: 10.1136/practneurol-2017-001848 |
12 |
Jiao YQ , Cai S , Lin J , et al. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China[J]. J Clin Neurosci, 2018, 57, 13- 19.
doi: 10.1016/j.jocn.2018.08.010 |
13 |
Landon-Cardinal O , Koumako C , Hardouin G , et al. Severe axial and pelvifemoral muscle damage in immune-mediated necrotizing myopathy evaluated by whole-body MRI[J]. Semin Arthritis Rheum, 2020, 50 (6): 1437- 1440.
doi: 10.1016/j.semarthrit.2020.02.009 |
14 |
Arouche-Delaperche L , Allenbach Y , Amelin D , et al. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies[J]. Ann Neurol, 2017, 81 (4): 538- 548.
doi: 10.1002/ana.24902 |
15 |
Hoogendijk JE , Amato AA , Lecky BR , et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands[J]. Neuromuscul Disord, 2004, 14 (5): 337- 345.
doi: 10.1016/j.nmd.2004.02.006 |
16 |
Allenbach Y , Mammen AL , Benveniste O , et al. 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies 14-16 October 2016, Zandvoort, The Netherlands[J]. J Neuromuscul Dis, 2018, 28 (1): 87- 99.
doi: 10.1016/j.nmd.2017.09.016 |
17 |
Landon-Cardinal O , Allenbach Y , Soulages A , et al. Rituximab in the treatment of refractory anti-HMGCR immune-mediated necrotizing myopathy[J]. J Rheumatol, 2019, 46 (6): 623- 627.
doi: 10.3899/jrheum.171495 |
18 | Gil-Núñez A , Masjuan J , Montaner J , et al. Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance[J]. Neurologia (Engl Ed), 2022, 37 (2): 136- 150. |
[1] | Lin-qi ZHANG,Jing ZHAO,Hong-yan WANG,Zong-yi WANG,Ying-ni LI,Ji-yang TANG,Si-ying LI,Jin-feng QU,Ming-wei ZHAO. Relationship between anti-ENO1 antibody and systemic lupus erythematosus patients with retinopathy [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1099-1105. |
[2] | Lu ZHANG,Cheng CHEN,Mei-ting WENG,Ai-ping ZHENG,Mei-ling SU,Qing-wen WANG,Yue-ming CAI. Characteristics of serum autoantibodies in patients with lupus nephritis and tubulointerstitial damage [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1094-1098. |
[3] | Jing-feng ZHANG,Xiu-ling YE,Meng DUAN,Xiao-li ZHOU,Zhong-qiang YAO,Jin-xia ZHAO. Clinical and laboratory characteristics of rheumatoid arthritis with positive antinuclear antibody [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1023-1028. |
[4] | Jing ZHAO,Feng SUN,Yun LI,Xiao-zhen ZHAO,Dan XU,Ying-ni LI,Yu-hui LI,Xiao-lin SUN. Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1009-1013. |
[5] | Yu-zhou GAN,Yu-hui LI,Li-hua ZHANG,Lin MA,Wen-wen HE,Yue-bo JIN,Yuan AN,Zhan-guo LI,Hua YE. Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1001-1008. |
[6] | Hong ZHU,Li-juan ZHAO,Yan ZHOU,Yao CHEN. Significance of anti-carbamylated protein antibodies in patients with rheumatoid arthritis-associated intersitial lung disease [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1003-1007. |
[7] | Li-yi DAI,Dan-dan GONG,Jin-xia ZHAO. Clinical characteristics of psoriatic arthritis with positive rheumatoid factor or anti-cyclic citrullinated peptide antibody [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1008-1013. |
[8] | Xue-jun LIANG,Li-ying GONG,Fei ZHOU,De-min ZHOU,Jing-jing ZHU. Pharmacological effects of site specific conjugated anti-human epidermal growth factor receptor 2-antibody drug conjugate using unnatural amino acid technology [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 797-804. |
[9] | Ji LI,Li ZHENG,Lian-jie SHI,Jing XU,Jian-long SHU,Xue-wu ZHANG. Increased serum soluble-endoglin level and its clinical significance in antiphospholipid syndrome [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1027-1032. |
[10] | Sheng-guang LI,Qing ZHANG,Hui-qiong ZHOU. Comparison of disease activities and extent measurements for anti-neutrophil cytoplasmic autoantibody-associated vasculitis [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1022-1026. |
[11] | LIU Hong-jiang, SHI Lian-jie, HU Fan-lei, YAO Hai-hong, LI Zhan-guo, JIAYuan. Increased serum C-C chemokine ligand 19 levels correlated with B cell abnormalities in systemic lupus erythematosus [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 829-834. |
[12] | ZHAO Shuang-Yun, LIU Ming, ZHAO Yu-Ming, LIN Qing-Jie, WANG Xiu-ping, GE Li-Hong. Spatiotemporal expression pattern of E-cadherin and P-cadherin during mouse tooth development [J]. Journal of Peking University(Health Sciences), 2015, 47(1): 42-46. |
|